CSN42369 is primarily used in research settings as a selective inhibitor targeting specific kinase pathways involved in cellular signaling. It has demonstrated utility in studies related to inflammation and immune response modulation due to its ability to suppress pro-inflammatory cytokine production. Its application extends to cancer research, where it helps investigate cell proliferation and apoptosis mechanisms in various tumor models. Due to its high selectivity and potency, CSN42369 is valuable in target validation experiments during early drug discovery. It is also employed in pharmacokinetic and pharmacodynamic studies to assess bioavailability and cellular uptake in preclinical models.